Form 4 for OTLK Outlook Therapeutics, Inc.
Accepted 2022-06-23 00:00:00 ET · period of report 2022-06-21 · accession 0001209191-22-038989 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-23 | 2022-06-21 | OTLK | Dagnon Terry | COO | P - Purchase | $1.05 | +10.0K | 1.17M | +0.9% | +$10.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-21 | P | A | 10,000 | $1.05 | 1,173,058 | D | — | — |